Vasospasm, Cerebral
11
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
9.1%
1 terminated out of 11 trials
80.0%
-6.5% vs benchmark
18%
2 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
Prevention of Vasospasm in SAH Through CSF Treatment
Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration
Early Warning of Delayed Cerebral Ischemia
Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
Brain Aneurysms: Utility of Cisternal Urokinase Irrigation
Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial